Junshi Bio covers $414m listing with big tickets
Shanghai Junshi Biosciences kicked off bookbuilding this week for a potential HK$3.24bn ($414.4m) IPO and by Thursday had the float covered across the price range, according to a banker on the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: